109 assets in Sarcoma

Therapeutic assets addressing Sarcoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ziv-Aflibercept Sarcoma	National Cancer Institute (NCI)	P1	C (39)
inn805 Sarcoma	FindCure Biosciences (ZhongShan) Co., Ltd.	Early P1	C (36)
Montelukast Sarcoma	University of South Florida	Early P1	C (36)
R130 Sarcoma	Shanghai Yunying Medical Technology	Early P1	C (36)
124i-humanized 3f8 Sarcoma	Memorial Sloan Kettering Cancer Center	N/A	D (30)
Sasanlimab Sarcoma	Pfizer	P1	D (30)
Soluble Fluorescein Sarcoma	Mayo Clinic	N/A	D (30)

Showing 101 to 109 of 109 assets

PreviousPage 3 of 3Next